INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 454m ago
House PTR54m ago
SEC 13F53m ago
Robinhood Chain53m ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

21,973 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
40
YR
Younessi RaminDirector
CRSCARPENTER TECHNOLOGY CORP
Open-market sale
SELL$399K
1,300 sh
Nov 21, 2025Nov 25, 2025
Page 509 of 550
← PrevNext →
traded Nov 21, 2025
+4d
SEC Form 4

Evidence

40
SF
Stanford FrederickPresident
IIIVi3 Verticals, Inc.
Open-market sale
SELL$275K
11.3K sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

39
SA
Singleton Philip Austin Jr.Director, Executive Chairman, See Remarks
ONEWOneWater Marine Inc.
Open-market purchase
BUY$495K
43.2K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

39
VV
Vitoc VladDirector, Chief Executive Officer, 10% Owner
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$1,656
1,800 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

38
BM
Brady Kevin M.CFO & Treasurer
MEDPMedpace Holdings, Inc.
Open-market sale
SELL$1.77M
3,000 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

38
VK
Vovra Niraj Kumar10% Owner
CREVCarbon Revolution Public Ltd Co
Open-market sale
SELL$218K
111.7K sh
Nov 18, 2025Nov 25, 2025
traded Nov 18, 2025
+7dSEC Form 4

Evidence

37
NV
Nathamuni VenkateshChief Financial Officer
JJACOBS SOLUTIONS INC.
Open-market purchase
BUY$101K
750 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

37
SR
Sylvester John RichardDirector
DCTHDELCATH SYSTEMS, INC.
Open-market purchase
BUY$39K
4,386 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

37
DV
Date Rajeev VDirector
CRCLCircle Internet Group, Inc.
Open-market sale
SELL$1.44M
20.0K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

36
GM
Gray Jonice MDirector
VACMARRIOTT VACATIONS WORLDWIDE Corp
Open-market purchase
BUY$60K
1,100 sh
Nov 25, 2025Nov 25, 2025
traded Nov 25, 2025
+0dSEC Form 4

Evidence

36
FA
Flees Lori AnnDirector, President & CEO
VVVVALVOLINE INC
Open-market purchase
BUY$139K
4,500 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

35
VV
Vitoc VladDirector, Chief Executive Officer, 10% Owner
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$9,891
10.0K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

35
WD
Woolson DanielVP, GM-Infusion Capital
ICUIICU MEDICAL INC/DE
Open-market sale
SELL$441K
2,897 sh
Nov 25, 2025Nov 25, 2025
traded Nov 25, 2025
+0dSEC Form 4

Evidence

35
SG
Schneider Terrence G.VP, SUPPLY CHAIN
DGIIDIGI INTERNATIONAL INC
Open-market sale
SELL$676K
16.7K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

34
EM
Eaton Timothy MathiasChief Financial Officer
APPFAPPFOLIO INC
Open-market sale
SELL$118K
517 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

32
HS
Hollenbeck Rupal SDirector
BLKBBLACKBAUD INC
Open-market sale
SELL$90K
1,600 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

31
KS
Karawan Gregory S.EVP and General Counsel
GNWGENWORTH FINANCIAL INC
Open-market sale
SELL$340K
40.0K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

31
MP
Mohideen PharisChief Medical Officer
DBVTDBV Technologies S.A.
Open-market sale
SELL$19K
6,496 sh
Nov 20, 2025Nov 25, 2025
traded Nov 20, 2025
+5dSEC Form 4

Evidence

31
DA
De Boo Alexander A.EVP & PRES - GLOBAL MARKETS
ECLECOLAB INC.
Open-market sale
SELL$381K
1,422 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

30
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$776K
41.2K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

29
YT
Young Michael T.Director
PDYNPalladyne AI Corp.
Open-market purchase
BUY$16K
3,000 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

29
LI
Liran IraDirector
COCOVita Coco Company, Inc.
Open-market sale · 10b5-1 plan
SELL$1.70M
33.9K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

28
RA
Rahman Jill ADirector
AMCRAmcor plc
Open-market sale
SELL$56K
6,596 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

28
WP
Watkins PhilipEVP, Head of Corp Development
CUBICustomers Bancorp, Inc.
Open-market sale
SELL$189K
2,900 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

27
GS
Garman Matthew SCEO Amazon Web Services
AMZNAMAZON COM INC
Open-market sale · 10b5-1 plan
SELL$1.80M
8,327 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

27
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Open-market sale
SELL$252K
25.0K sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

27
RD
Raben DavidChief Medical Officer
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$101K
5,500 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

26
UA
Unterseher Loren ADirector, 10% Owner
SKYTSkyWater Technology, Inc
Open-market sale
SELL$1.41M
100.0K sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

26
UA
Unterseher Loren ADirector, 10% Owner
SKYTSkyWater Technology, Inc
Open-market sale
SELL$1.45M
100.0K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

26
HI
Hyep IvanChief Financial Officer
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$330K
17.8K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

25
LI
Liran IraDirector
COCOVita Coco Company, Inc.
Open-market sale · 10b5-1 plan
SELL$1.28M
25.4K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

24
SG
Schneider Terrence G.VP, SUPPLY CHAIN
DGIIDIGI INTERNATIONAL INC
Open-market sale
SELL$175K
4,208 sh
Nov 25, 2025Nov 25, 2025
traded Nov 25, 2025
+0dSEC Form 4

Evidence

24
WS
Wilson SimonCEO, Markel Insurance
MKLMARKEL GROUP INC.
Open-market sale
SELL$155K
75 sh
Nov 25, 2025Nov 25, 2025
traded Nov 25, 2025
+0dSEC Form 4

Evidence

24
GS
Garman Matthew SCEO Amazon Web Services
AMZNAMAZON COM INC
Open-market sale · 10b5-1 plan
SELL$743K
3,413 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

24
GS
Garman Matthew SCEO Amazon Web Services
AMZNAMAZON COM INC
Open-market sale · 10b5-1 plan
SELL$376K
1,721 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

24
SE
Shroff EricSenior Vice President
ABTABBOTT LABORATORIES
Open-market sale
SELL$203K
1,586 sh
Nov 25, 2025Nov 25, 2025
traded Nov 25, 2025
+0dSEC Form 4

Evidence

23
RD
Raben DavidChief Medical Officer
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$87K
4,594 sh
Nov 25, 2025Nov 25, 2025
traded Nov 25, 2025
+0dSEC Form 4

Evidence

23
CR
Cohlhepp RyanDirector, President and COO
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$81K
4,500 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence

23
PA
Polovin AndrewEVP and General Counsel
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$966K
12.9K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC Form 4

Evidence

23
CR
Cohlhepp RyanDirector, President and COO
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$144K
8,000 sh
Nov 21, 2025Nov 25, 2025
traded Nov 21, 2025
+4dSEC Form 4

Evidence